| Budget Amount *help |
¥15,340,000 (Direct Cost: ¥11,800,000、Indirect Cost: ¥3,540,000)
Fiscal Year 2018: ¥2,600,000 (Direct Cost: ¥2,000,000、Indirect Cost: ¥600,000)
Fiscal Year 2017: ¥2,730,000 (Direct Cost: ¥2,100,000、Indirect Cost: ¥630,000)
Fiscal Year 2016: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2015: ¥2,730,000 (Direct Cost: ¥2,100,000、Indirect Cost: ¥630,000)
Fiscal Year 2014: ¥5,200,000 (Direct Cost: ¥4,000,000、Indirect Cost: ¥1,200,000)
|
|---|
| Outline of Final Research Achievements |
Outcomes of the present research are as follows; (1) We found that sharp images are obtained by the combination of developed endoscope and intraoral camera, and that the endoscope may be useful for the observation of curved root canals; (2) We found that MTI-II derived peptide, MPAID, suppresses the inflammatory responses of hard tissue-forming cells, and that GDNF secreted from capsules for Encapsulated Cell Therapy can prolong the survival of odontoblast-like cells; (3) We found that bioactive glass (BG)-included cement prototype shows high sealing ability and biocompatibility and it has been commercialized, and that hydroxyapatite is formed on the surface of BG-included gelatin sponge in simulated body fluid.
|
